Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic (HOLX) Advances But Underperforms Market: Key Facts
In the most recent trading session, Hologic (HOLX) closed at $61.89, indicating a +0.68% shift from the previous trading day.
New Product Launches to Support HOLX Stock Amid Macro Issues
Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global markets.
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?
As Hologic works through the changing macroeconomic and geopolitical landscape, its long-term potential makes it a solid hold.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report?
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock?
HOLX's latest regulatory successes draw investors' attention. However, macroeconomic challenges restrict its full growth potential.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Two S&P 500 hidden gems to buy right now
Although the benchmark S&P 500's biggest names tend to dominate investor attention, the index also features lesser-known stocks with significant growth potential.
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes
Hologic's Surgical business has been recording strong broad-based performance by expanding access to technologies into new global markets.
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
Hologic's strength in the molecular diagnostics wing instills optimism among investors. Yet, a dull macroeconomic environment raises concerns.
